Millennium Management’s Matinas BioPharma MTNB Stock Holding History

Millennium Management’s Portfolio MTNB Stock Details MTNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-24	Closed	-$6.4K	–	6399
2023 Q2	$6.4K	Sell	24 -259	-92%	-$90.6K	﹤0.01%	5828
2023 Q1	$100K	Sell	283 -36	-11%	-$13.6K	﹤0.01%	5427
2022 Q4	$120K	Buy	+319	New	+$159K	﹤0.01%	5513
2021 Q2	–	Sell	-39	Closed	-$31K	–	6883
2021 Q1	$31K	Sell	39 -546	-93%	-$549K	﹤0.01%	5802
2020 Q4	$597K	Buy	585 +520	+800%	+$361K	﹤0.01%	4068
2020 Q3	$37K	Sell	65 -468	-88%	-$279K	﹤0.01%	4318
2020 Q2	$309K	Sell	533 -745	-58%	-$429K	﹤0.01%	3646
2020 Q1	$575K	Buy	1,278 +1,152	+914%	+$1.04M	﹤0.01%	2799
2019 Q4	$214K	Sell	126 -392	-76%	-$341K	﹤0.01%	3843
2019 Q3	$244K	Sell	518 -244	-32%	-$132K	﹤0.01%	3679
2019 Q2	$489K	Sell	762 -530	-41%	-$382K	﹤0.01%	3251
2019 Q1	$1.06M	Buy	+1,292	New	+$1.04M	﹤0.01%	2831
2018 Q4	–	Sell	-100	Closed	-$69K	–	4027
2018 Q3	$69K	Sell	100 -198	-66%	-$63.8K	﹤0.01%	3776
2018 Q2	$97K	Buy	+298	New	+$129K	﹤0.01%	3654
2017 Q3	–	Sell	-68	Closed	-$86K	–	3734
2017 Q2	$86K	Sell	68 -343	-83%	-$691K	﹤0.01%	3316
2017 Q1	$854K	Buy	+411	New	+$1.01M	﹤0.01%	2494

Other funds holding MTNB

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Sargent Investment Group Bethesda, Maryland $832M AUM 24.89% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Arkadios Wealth Advisors Atlanta, Georgia $6.6B AUM 30.67% 1-Year Est. Return

Neville Rodie & Shaw New York $1.48B AUM 34.49% 1-Year Est. Return

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Millennium Management's MTNB Position: Q3 2023 in Review

Millennium Management sold out of Matinas BioPharma (MTNB) in Q3 2023, closing a stake of 24 shares — an estimated $6.4K sold.

Millennium Management first reported a position in MTNB in Q1 2017 and held it in 16 quarters. The position peaked at $1.06M in Q1 2019. 47 funds tracked by Wall St. Rank hold MTNB as of Q3 2023.

Millennium Management reported no remaining Matinas BioPharma position as of Q3 2023 after selling out during the quarter.
Millennium Management sold 24 Matinas BioPharma shares in Q3 2023, an estimated $6.4K.
Millennium Management first reported a position in Matinas BioPharma in Q1 2017 and held it in 16 quarters.
Millennium Management's Matinas BioPharma position peaked at $1.06M in Q1 2019.
47 funds tracked by Wall St. Rank held Matinas BioPharma as of Q3 2023.

Based on Millennium Management's 13F filing for Q3 2023, filed 14 Nov 2023.